Testosterone
Who holds supplier records for Testosterone? 15 organisations hold a current record for Testosterone: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (5), India (5), Netherlands (1), Germany (1) and 2 other countries (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Testosterone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/testosterone
Reading the evidence
- 15 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Testosterone expires 17 Mar 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (15)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Testosterone. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ASPEN OSS BVNetherlandsCEP Company GMP cert on recordActive DMF 11826 · latest filing Jan 1996
- Bayer AGGermanyCEP Company GMP cert on recordActive DMF 15077 · latest filing Oct 2000
- CURIA SPAIN SAUSpainCEP Company GMP cert on recordActive DMF 32817 · latest filing Jun 2018
- Hubei Zhuxi Humanwell Pharmaceutical Co. Ltd.ChinaCEPActive DMF 37074 · latest filing Sept 2022
- Pharmacia & Upjohn, Inc.United StatesCEPActive DMF 3190 · latest filing Apr 1978
- SYMBIOTEC PHARMALAB PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 29869 · latest filing Sept 2015
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 23671 · latest filing Jun 2010
- HUBEI GOTO BIOTECHNOLOGY CO LTDChinaActive DMF 33118 · latest filing Sept 2018
- Lupin LimitedIndia Company GMP cert on recordActive DMF 30377 · latest filing Apr 2016
- Sightlead Pharmaceutical Co., Ltd.ChinaActive DMF 44479 · latest filing Aug 2026
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 27447 · latest filing Oct 2013
- ZHEJIANG XIANJU PHARMACEUTICAL CO LTDActive DMF 44681 · latest filing Sept 2026
- ChinaCEP
- ChinaCEP
- SHAKTI LIFESCIENCE PRIVATE LIMITEDIndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (9)
Certificates of Suitability on the EDQM register for Testosterone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HUBEI ZHUXI HUMANWELL PHARMACEUTICAL CO., LTD. Shiyan | CN | CEP 2022-181 - Rev 02 Testosterone, Micronised, non-micronised | Oct 2026 | — |
| BAYER AG Leverkusen | DE | CEP 2000-231 - Rev 05 Testosterone | Jun 2026 | — |
| SYMBIOTEC PHARMALAB LIMITED Indore | IN | CEP 2015-314 - Rev 02 Testosterone, Micronised | Mar 2026 | Inspected Mar 2026 Germany |
| JIANGSU JIAERKE PHARMACEUTICALS GROUP CO., LTD. Changzhou | CN | CEP 2023-439 - Rev 00 Testosterone | Nov 2025 | — |
| SHAKTI LIFESCIENCE PRIVATE LIMITED Mumbai | IN | CEP 2023-267 - Rev 00 Testosterone | Mar 2025 | — |
| CURIA SPAIN S.A.U. Boecillo | ES | CEP 2017-314 - Rev 04 Testosterone | Nov 2024 | Inspected Feb 2026 Spain |
| ASPEN OSS B.V. Oss | NL | CEP 2023-084 - Rev 00 Testosterone isocaproate | Oct 2024 | Inspected Oct 2025 Netherlands |
| PHARMACIA & UPJOHN COMPANY LLC Kalamazoo | US | R1-CEP 2000-307 - Rev 03 Testosterone, Non-micronised, micronised | Feb 2021 | — |
| QINHUANGDAO ZIZHU PHARMACEUTICAL CO., LTD. Qinhuangdao City | CN | R1-CEP 2013-232 - Rev 00 Testosterone | Jan 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (7)
Organisations whose Type II DMFs for Testosterone are no longer active. These show a past filing, not current supply.
Show all 7 historical records
- INDO PHYTO CHEMICALS PRIVATE LTDInactive DMF 26430 · filed Sept 2012
- BIOVET JOINT STOCK COInactive DMF 23157 · filed Sept 2009
- India · Inactive DMF 21546 · filed Aug 2008
- SIGMA F AND D DIV LTDInactive DMF 9931 · filed Nov 1992
- SCHERING AGInactive DMF 4695 · filed Oct 1982
- ROUSSELL UCLAFInactive DMF 4512 · filed Apr 1982
- DIOSYNTH BVInactive DMF 3974 · filed Oct 1980
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (36 listed products contain Testosterone). The latest listed patent expires 17 Mar 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Testosterone is a steroid hormone primarily responsible for the development of male reproductive tissues and secondary sexual characteristics. It is also used in hormone therapy to treat certain conditions in both men and women.
Chemical identity
- IUPAC name
- (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
- Canonical SMILES
- C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C
- InChIKey
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N
- Synonyms
- AndroGel API, androderm, androgel, android-t, androlan, homosterone, intrinsa, livensa, mertestate, natesto, nsc-9700, testiculosterone
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Androgen
- Mechanism of action
- Androgen Receptor Agonists
- Chemical structure
- Androstanes
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Testosterone?
15 organisations hold an active US FDA Type II Drug Master File or a CEP for Testosterone: ASPEN OSS BV (Netherlands), Bayer AG (Germany), CURIA SPAIN SAU (Spain), Hubei Zhuxi Humanwell Pharmaceutical Co. Ltd. (China), Pharmacia & Upjohn, Inc. (United States), SYMBIOTEC PHARMALAB PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India) and HUBEI GOTO BIOTECHNOLOGY CO LTD (China), and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Testosterone Drug Master Files are active?
ASPEN OSS BV (DMF 11826), Bayer AG (DMF 15077), CURIA SPAIN SAU (DMF 32817), Hubei Zhuxi Humanwell Pharmaceutical Co. Ltd. (DMF 37074), Pharmacia & Upjohn, Inc. (DMF 3190), SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 29869), Dr. Reddy's Laboratories Ltd. (DMF 23671) and HUBEI GOTO BIOTECHNOLOGY CO LTD (DMF 33118) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Testosterone records mean?
7 organisations have only inactive Type II DMFs for Testosterone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Testosterone have a European Certificate of Suitability?
Yes. 9 organisations hold a valid CEP for Testosterone on the EDQM register, including HUBEI ZHUXI HUMANWELL PHARMACEUTICAL CO., LTD. Shiyan (CN), BAYER AG Leverkusen (DE), SYMBIOTEC PHARMALAB LIMITED Indore (IN), JIANGSU JIAERKE PHARMACEUTICALS GROUP CO., LTD. Changzhou (CN), SHAKTI LIFESCIENCE PRIVATE LIMITED Mumbai (IN) and CURIA SPAIN S.A.U. Boecillo (ES) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Testosterone?
Yes. The latest patent listed for an approved US product containing Testosterone expires 17 Mar 2034, across 36 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Testosterone supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Testosterone?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.